Mirus Bio
Nicholas Rossi's work experience began in 2003 as a Postdoctoral Fellow at the University of Wisconsin-Madison. Nicholas then moved on to work as a Research Associate at The University of British Columbia from 2006 to 2010, where they focused on polymer cell derivatization technology and macromolecular therapeutics. In 2010, Nicholas became a Senior Scientist at Roche Madison Inc. before joining Mirus Bio LLC in 2012 as a Senior Scientist II. Nicholas later transitioned to the role of Director of Chemistry at Mirus Bio LLC in October 2019.
Nicholas Rossi completed their Bachelor of Science (BSc) degree in Chemistry with Environmental Sciences from the University of Kent from 1995 to 1998. Nicholas then pursued further studies at the same university and obtained their Doctor of Philosophy (PhD) degree in Polymer Chemistry from 1998 to 2002.
This person is not in any teams
Mirus Bio
1 followers
Mirus Bio Corporation, a life science company, discovers, develops, and commercializes nucleic acid based technologies and products. It provides transfection reagents, electroporation kits and solutions, DNA and RNA labeling reagents, in vivo delivery products, and accessories. The company offers its products through distributors in Argentina,Australia, Austria, Belgium, Bangladesh, Canada, Chile, the People's Republic of China, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Iceland, India, Indonesia, Ireland, Israel, Japan, Korea, Malaysia, the Netherlands, New Zealand, Norway, the Philippines, Portugal, Singapore, Slovenia, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, the United Kingdom, the United States, and Vietnam. Mirus Bio Corporation was formerly known as Mirus Corporation. The company was founded in 1995 and is based in Madison, Wisconsin. As of September 30, 2008, Mirus Bio Corporation operates as a subsidiary of Roche Holding AG.